The cost-effectiveness of tafenoquine following screening with STANDARD™ G6PD screening for the treatment of vivax malaria in the Brazilian Public Health System
Authors
Marcus Lacerda (ORCID: https://orcid.org/0000-0003-3374-9985)
The cost-effectiveness of tafenoquine following screening with STANDARD™ G6PD screening for the treatment of vivax malaria in the Brazilian Public Health System
Marcus Lacerda, Wuelton Marcelo Monteiro, Vanderson de Souza Sampaio, Angela Devine et al.
Citations
1 citations
Journal
The Lancet Regional Health - Americas
Topics
Malaria Research and Control
Field-Weighted Citation Impact (FWCI)
1.88
article
The cost-effectiveness of tafenoquine following screening with STANDARD™ G6PD screening for the treatment of vivax malaria in the Brazilian Public Health System
Marcus Lacerda, Wuelton Marcelo Monteiro, Vanderson de Souza Sampaio, Angela Devine, Elodie Jambert, José Diego Brito-Sousa, Henry Maia Peixoto, Penny Grewal Daumerie, Luiza Lena Bastos Gottin
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
The Lancet Regional Health - AmericasVol. 51
Institutions
Universidade de Brasília (BR), The University of Melbourne (AU), Charles Darwin University (AU), Menzies School of Health Research (AU), Fundação de Medicina Tropical (BR), Fundação Saúde (BR), Escola Superior de Ciências da Saúde (BR), Universidade do Estado do Amazonas (BR), Medicines for Malaria Venture (CH)
Funders
Medicines for Malaria Venture, Medical Research Council, National Health and Medical Research Council